Van Thiel DH et al. |
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689893
|
Mieles L et al. |
Oral glucose tolerance test in liver recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689894
|
Alessiani M et al. |
Infections with FK 506 immunosuppression: preliminary results with primary therapy. |
1990 |
Transplant. Proc. |
pmid:1689895
|
Staschak S et al. |
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. |
1990 |
Transplant. Proc. |
pmid:1689896
|
|
Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings. |
1990 |
Transplant. Proc. |
pmid:1689897
|
Cadoff EM et al. |
Assay of FK 506 in plasma. |
1990 |
Transplant. Proc. |
pmid:1689898
|
Saitoh Y et al. |
Morphological rejection phases and cytotoxic activity in peripheral blood lymphocytes in canine lung allo-transplantation. |
1990 |
Jpn J Surg |
pmid:1692892
|
Rosen MK et al. |
Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. |
1990 |
Science |
pmid:1693013
|
Thomas FT et al. |
Comparative efficacy of immunosuppressive drugs in xenografting. |
1990 |
Transplant. Proc. |
pmid:1693452
|
Harrison RK and Stein RL |
Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. |
1990 |
Biochemistry |
pmid:1693856
|
Starzl TE et al. |
Kidney transplantation under FK 506. |
1990 |
JAMA |
pmid:1693970
|
Bierer BE et al. |
Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. |
1990 |
Transplantation |
pmid:1694317
|
Eiras G et al. |
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. |
1990 |
Transplantation |
pmid:1694318
|
Tsuji RF et al. |
Selective immunosuppression of prodigiosin 25-C and FK506 in the murine immune system. |
1990 |
J. Antibiot. |
pmid:1701765
|
Granelli-Piperno A et al. |
The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. |
1990 |
J. Exp. Med. |
pmid:1701825
|
Lee KK et al. |
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. |
1990 |
Transplant. Proc. |
pmid:1702239
|
Takai K et al. |
Effects of FK506 on rat thymus: time-course analysis by immunoperoxidase technique and flow cytofluorometry. |
1990 |
Clin. Exp. Immunol. |
pmid:1702372
|
Okubo Y et al. |
FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. |
1990 |
Clin. Exp. Immunol. |
pmid:1702373
|
Arita C et al. |
Inhibition by FK506 of established lesions of collagen-induced arthritis in rats. |
1990 |
Clin. Exp. Immunol. |
pmid:1702374
|
Akutsu I et al. |
[Inhibitory effect of FK-506 on the development of late asthmatic response and on the increased bronchial responsiveness]. |
1990 |
Arerugi |
pmid:1705791
|